HERAMED LIMITED — Director's Dealing 2025

Feb 17, 2025

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HERAMED LIMITED
ABN	65 626 295 314

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	ANOUSHKA GUNGADIN
Date of last notice	28 June 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	-
Date of change	12 February 2025
No. of securities held prior to change ANOUSHKA GUNGADIN	- 850,000 unlisted options with an exercise price of $0.1358 expiring 28/07/2027 - 5,000,000 unlisted options with an exercise price of $0.02 expiring 26/06/2028

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class		Number of	Vesting Condition	Exercise Date – Exercise no
		Performance		later than
		Rights
		2,633,860	Share price* of 100% premium to share price at date of issue by 12 February 2026	18 months from vesting
		2,633,860	Share price* of 200% premium to share price at date of issue by 12 February 2027	18 months from vesting
		2,632,280	Share price* of 300% premium to share price at date of issue by 12 February 2030	18 months from vesting
		2,633,860	7,500 paid mums (accumulated) on HeraCARE platform by 30 June 2026	31 December 2027
		2,633,860	11,500 paid mums (accumulated) on HeraCARE platform by 30 June 2026	31 December 2027
		2,632,280 23,000 paid mums (accumulated) on HeraCARE platform by 30 June 2027 31 December 2028 Share price for the purposes of satisfying the Vesting Condition for classes 1, 2_ and 3 in the table above is measured on a 20 day volume weighted average price (VWAP*)._
Number acquired		15,800,000
Number disposed		-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil
No. of securities held after change		- 850,000 unlisted options with an exercise price of $0.1358 expiring 28/07/2027 - 5,000,000 unlisted options with an exercise price of $0.02 expiring 26/06/2028 - 15,800,000 Performance Rights 1. 2,633,860 Share price of 100% premium to share price at date of issue by 12 February 2026 expiring 18 months from vesting 2. 2,633,860 Share price of 200% premium to share price at date of issue by 12 February 2027 expiring 18 months from vesting 3. 2,632,280 Share price* of 300% premium to share price at date of issue by 12 February 2030 expiring 18 months from vesting 4. 2,633,860 7,500 paid mums (accumulated) on HeraCARE platform by30 June 2026 expiring31 December 2027

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

1. 11,500 paid mums (accumulated) on HeraCARE platform by 30 June 2026 expiring 31 December 2027

2. 23,000 paid mums (accumulated) on HeraCARE platform by 30 June 2027 expiring 31 December 2028

Share price for the purposes of satisfying the Vesting Condition for classes 1, 2 and 3 in the table above is measured on a 20 day volume weighted average price ( VWAP* ).

Nature of change Issue of Performance Rights approved at General Meeting on 19 Example: on-market trade, off-market trade, December 2024. exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 4